Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

New Cholesterol-Lowering Drugs Near FDA Approval

Two new drugs to help physicians better manage “bad” cholesterol (LDL cholesterol) have received approval this week from an FDA advisory panel. The FDA typically accepts those recommendations, so the drugs may soon be available for patient use. The new drugs – both injectables – are called alirocumab (brand name, Praluent), which received the panel’s … Read More

Advertising Policy